Latest Australian Taxation Office News

Recce Pharmaceuticals reports strong Phase II clinical trial results for its topical anti-infective R327G, achieving a 93% efficacy rate in treating ABSSSI, alongside a significant capital raise to fund upcoming Phase III trials.

Oldfields Holdings Limited reports solid progress in Q3 FY2025, driven by strategic transformation, debt reduction, and a robust sales pipeline supporting a positive outlook for the second half of the year.

AdNeo Limited reports a positive operating cash flow for Q3 FY25, driven by a 60% surge in customer receipts and cost savings exceeding targets. Strategic SaaS contracts and platform upgrades underpin its growth trajectory.

Cadoux Limited has made significant progress in its High Purity Alumina and Minhub rare earth projects during Q1 2025, advancing engineering studies, securing key contracts, and strengthening ESG initiatives while preparing for commercialisation.

Indiana Resources reports significant high-grade gold assay results extending the Minos Southwest Zone and deepening mineralisation, alongside a strong cash position and corporate developments including a proposed capital return.

Alterity Therapeutics reports compelling Phase 2 clinical trial results for ATH434 in Multiple System Atrophy, alongside a significant capital raise strengthening its financial position for upcoming regulatory milestones.

N1 Holdings Limited reported a solid FY25 year-to-date profit with revenue growth driven by its SME lending business, while successfully reducing funding costs and maintaining disciplined operations amid ongoing market volatility.

Careteq Limited reports strong Q3 FY25 progress with near completion of its 1-System platform integration, revenue growth exceeding forecasts, and new strategic partnerships broadening its healthcare footprint.

Dubber Corporation Limited reported a 6% quarter-on-quarter revenue increase to $11 million in Q3 FY25, alongside a 7% reduction in cash-based costs, positioning the company to achieve operating cash flow breakeven by June 2025.

Bravura Solutions has received a final Class Ruling from the Australian Taxation Office clarifying the tax treatment of its recent $0.163 per share capital return, providing certainty for shareholders holding shares on capital account.

Suncorp Group Limited has announced a cash return of capital of AUD 3.00 per share, backed by shareholder and regulatory approvals, with payments scheduled for early March 2025.

Suncorp Group Limited has announced a combined ordinary and special dividend totaling AUD 0.63 per security, fully franked and backed by APRA approval for a capital reduction. The payment is scheduled for mid-March 2025.